Name: 微射频治疗系统治疗膀胱过度活动症临床试验数据集（表3）
Creator: 千方医数集科研发现管道
License: CC BY 4.0

基本信息

模态

表格

大小

0.000141806 GB

许可

CC BY 4.0

创建/更新时间

2026-10-07

版本

v1

资源简介

微射频治疗系统治疗膀胱过度活动症临床试验数据集（表3）

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集，收录 1 个文件、合计 141.81 KB，主题涵盖 micro radiofrequency、overactive bladder、urinary incontinence、urgency、minimally invasive，可用于统计建模、特征工程与队列分析，CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Table_3_A Multi-Center, Randomized, Blind, Controlled Clinical Trial of the Safety and Efficacy of Micro Radio Frequency Therapy System for the Treatment of Overactive Bladder.pdf》。配套论文《Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019》发表于 Journal of Urology（2019），DOI：10.1097/JU.0000000000000309。源站首次发布：2022-05-12。

【数据内容】

源站原始描述：PurposeThe purpose of this study was to evaluate the efficacy and safety of low power micro radiofrequency (RF) therapy (μRFthera®) through urethra in the treatment of overactive bladders (OAB) through a prospective, single-blind, placebo-controlled, multi-center clinical protocol. Materials and MethodsOne hundred and fourteen patients with refractory OAB were randomized at 2:1 ratio, treatment to control undergoing same procedures except only the micro-RF treatment group at turned “on” setting…

中文译文（机器翻译，仅供快速理解，请以原文为准）：目的本研究旨在通过前瞻性、单盲、安慰剂对照的多中心临床方案，评估经尿道低功率微型射频（RF）治疗（μRFthera®）治疗膀胱过度活动症（OAB）的有效性和安全性。材料与方法一百一十四例难治性OAB患者按2：1比例随机分为治疗组和对照组，接受相同操作，仅微型射频治疗组设置为能量“开启”状态。膀胱日记分别记录于筛选期（入组前3天）及随访期第1、3、7周。对照组患者可在延展阶段选择接受能量开启的治疗。结果治疗有效率为76.1%。与对照组相比，改善率为49.80%（95%CL 32.48%，67.13%）。粗率比（RR）为2.89，95%CI（1.67–5.01），p微型射频治疗对OAB安全有效。主要治疗相关并发症为导尿相关并发症。临床试验注册浙江器械注册证号202090909，www.chictr.org.cn，临床试验注册号：ChiCTR2100050096。

【数据结构与技术规格】

文件数 1 个，合计 141.81 KB。Table_3_A Multi-Center, Randomized, Blind, Controlled Clinical Trial of the Safety and Efficacy of Micro Radio Frequency Therapy System for the Treatm.pdf：application/pdf，141.81 KB。数据集 DOI：10.3389/fmed.2022.746064.s003。

【主题与分类】

源站学科分类：Radiology and Organ Imaging、Foetal Development and Medicine、Obstetrics and Gynaecology、Primary Health Care、Medical and Health Sciences not elsewhere classified、Dermatology。主题标签：micro radiofrequency、overactive bladder、urinary incontinence、urgency、minimally invasive。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面：https://frontiersin.figshare.com/articles/dataset/Table_3_A_Multi-Center_Randomized_Blind_Controlled_Clinical_Trial_of_the_Safety_and_Efficacy_of_Micro_Radio_Frequency_Therapy_System_for_the_Treatment_of_Overactive_Bladder_pdf/19752247

使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。

规范引用：Xu, Zhi-Hui; Zhang, Peng-Fei; Wang, Yu-Feng; Ma, Ao; Bano, Yasmeen; Ibrohimov, Alisherjon; et al. (2022). Table_3_A Multi-Center, Randomized, Blind, Controlled Clinical Trial of the Safety and Efficacy of Micro Radio Frequency Therapy System for the Treatment of Overactive Bladder.pdf. Frontiers. Da…

【使用注意】

· 源站最后修改于 2023-06-05，引用时请注意版本时效。

原始链接

https://figshare.com/articles/dataset/Table_3_A_Multi-Center_Randomized_Blind_Controlled_Clinical_Trial_of_the_Safety_and_Efficacy_of_Micro_Radio_Frequency_Therapy_System_for_the_Treatment_of_Overactive_Bladder_pdf/19752247

访问原始数据

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付，我们提供全链路闭环服务，让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持？联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载，适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档，适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务（收技术服务费，非数据销售）

暂未开放

当前数据集主要来源为 Kaggle 公开托管，完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取（Figshare）

源站标题：Table_3_A Multi-Center, Randomized, Blind, Controlled Clinical Trial of the Safety and Efficacy of Micro Radio Frequency Therapy System for the Treatment of Overactive Bladder.pdf
DOI：10.3389/fmed.2022.746064.s003
发布日期：2022-05-12
文件数：1 个
文件总体积：141.81 KB
源站页面：https://frontiersin.figshare.com/articles/dataset/Table_3_A_Multi-Center_Randomized_Blind_Controlled_Clinical_Trial_of_the_Safety_and_Efficacy_of_Micro_Radio_Frequency_Therapy_System_for_the_Treatment_of_Overactive_Bladder_pdf/19752247

命令行下载

curl -L -o "Table_3_A Multi-Center, Randomized, Blind, Controlled Clinical Trial of the Safety and Efficacy of Micro Radio Frequency Therapy System for the Treatm.pdf" "https://ndownloader.figshare.com/files/35096089"

文件清单

Table_3_A Multi-Center, Randomized, Blind, Controlled Clinical Trial of the Safety and Efficacy of Micro Radio Frequency Therapy System for the Treatm.pdf（141.81 KB）

文件总体积 141.81 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

PurposeThe purpose of this study was to evaluate the efficacy and safety of low power micro radiofrequency (RF) therapy (μRFthera®) through urethra in the treatment of overactive bladders (OAB) through a prospective, single-blind, placebo-controlled, multi-center clinical protocol.
Materials and MethodsOne hundred and fourteen patients with refractory OAB were randomized at 2:1 ratio, treatment to control undergoing same procedures except only the micro-RF treatment group at turned “on” setting in energy. Bladder diaries recorded during the screening period (3 days before enrollment) and during follow-up period on week 1, 3, and 7, respectively. The patients in control could choose receiving an energized treatment during extension stage.
ResultsThe treatment efficacy was 76.1%. There was 49.80% rate improvement compared to control (95%CL 32.48%, 67.13%). The crude rate ration (RR) was 2.89, 95% CI (1.67–5.01) with p Micro RF therapy is safe and effective for the treatment of OAB. The main treatment-related complications were catheterization related complications.
Clinical Trial RegistrationZhejiang Device Registration Certificate No. 202090909, www.chictr.org.cn, Clinical Trial Accession Number: ChiCTR2100050096.